• Information for health professionals conference 2011
  • Information for health professionals conference 2013
  • Information for health professionals conference 2011
  • Information for young doctors
  • Information for health professionals

ASCIA Members

ASCIA Members have access to the restricted area of the website. Access requires a username and password.

When logged in members have the special Members Menu available which provides the following information to ASCIA members.

ASCIA Council 2012-2014

ASCIA Council elections for Executive and Area Representatives were held at the ASCIA 2012 Annual General Meeting on Friday 7 September 2012 at the Wellington Town Hall. A list of all ASCIA Council members for 2012-2014 is available. (List of ASCIA Council Members)

Allergy and Immunology Foundation of Australasia (AIFA)

AIFA is an initiative of ASCIA and was launched in September 2013.  The aim of AIFA is to provide funding to support education and research into disorders of the human immune system in Australia and New Zealand. These disorders comprise allergic diseases (including asthma) primary immunodeficiency diseases and autoimmune diseases.

For further information visit www.allergyimmunology.org.au or email This email address is being protected from spambots. You need JavaScript enabled to view it.   

Allergy and Immune Diseases Report

The Allergy and Immune Diseases in Australia (AIDA) report was developed by ASCIA in 2013. It is available on the ASCIA website:


We plan to have a New Zealand version in 2014. 

ASCIA Constitution

The ASCIA Constitution is available here, including changes that were voted on at the ASCIA Annual General Meetings on 12 November 2008 and 16 September 2009.

(You must be logged in to view.)

Draft Information to review

ASCIA members are invited to comment on draft information that will eventually appear in the public section of the ASCIA website.

(You must be logged in to view)

ASCIA Members Newletters

Newsletters are available to view here (when logged in) 

Access to skin prick testing reagents

In 2008 Hollister Stier food allergen extracts for skin prick testing (SPT) were discontinued. For details on which food allergens are still available contact Stallergenes (see details below).

Medical practitioners can access currently unregistered diagnostic SPT extracts (Stallergenes Alyostal or ALK-Abello) using one of the following options:

(1) Section 19(5): Obtain "Authorised Prescriber status" by endorsement from the Royal Australasia College of Physicians (RACP) or the Royal College of Pathologists of Australasia (RCPA). This has now been obtained by ASCIA on behalf of its Full (ordinary) members who are fellows of the RACP or RCPA for both Stallergenes-Alyostal and ALK-Abello skin prick testing reagents. ASCIA members need to email This email address is being protected from spambots. You need JavaScript enabled to view it. to obtain the necessary documentation.

(2) Section 19(5): Obtain "Authorised Prescriber status" by endorsement by an ethics committee (possible for some but not all ASCIA members who work outside hospitals/universities).


Products available by the TGA 'Authorised Prescriber' option are not registered in Australia. Users are reminded that patient consent needs be obtained before use and there are also reporting requirements to the TGA about their use.

Histamine Positive Control is available from Stallergenes under Section 19A2 of the of the Therapeutic Goods Act 1989, as Histamine is not currently registered by the Therapeutic Goods Administration (TGA) for use in Australia. As this does not require Authorised Prescriber status it is open to all medical practitioners, without endorsement.

Contact information
Hollister Stier and Stallergenes therapeutic and diagnostic products are distributed by EBOS
Email:  This email address is being protected from spambots. You need JavaScript enabled to view it.
Phone: 1800 824 166
ALK-Abello products are distributed by Australasian Medical and Scientific Limited
Email: This email address is being protected from spambots. You need JavaScript enabled to view it. or This email address is being protected from spambots. You need JavaScript enabled to view it.
Phone: 02 9882 3666 or 0448 022 855 (Steve Lee)

Diater-DAP skin prick testing reagents for penicillin allergy testing are also available from Australasian Medical and Scientific, subject to a separate Authorised Prescriber application.

Information for ASCIA members

ASCIA Oral Food Challenge Protocols

To access the PDF go to ASCIA Food Challenge Protocols (you must be logged in to view).

ASCIA oral food challenge protocols (for peanut, cow's milk, soy milk, wheat, cooked egg and baked egg) are used by ASCIA members to:

  • confirm suspected food allergies
  • identify useful food alternatives to known food allergies
  • confirm tolerance to foods when it appears likely that previous allergy has been outgrown.

Oral food allergen challenges can result in potentially life threatening anaphylaxis and should therefore only be carried out by medical practitioners in carefully selected patients, under strict medical supervision and in consultation with a clinical immunology/allergy specialist. For contact details of clinical immunology/allergy specialists who are experienced in using the ASCIA Oral Food Allergen Challenge protocols please email This email address is being protected from spambots. You need JavaScript enabled to view it.

ASCIA Oral Food Allergen Challenge Protocols were developed by ASCIA members to standardise the protocols for food challlenges used by clinical immunology/allergy specialists in Australia and New Zealand. They have been peer reviewed by ASCIA members and are based on expert opinion and the available published literature at the time of review. The development of these protocols is not funded by any commercial sources and is not influenced by commercial organisations. Clinical studies using these protocols are currently being conducted and protocols may be modified in the future, based on study outcomes.

ASCIA template letter regarding temporary allergen immunotherapy supply issue

The following letter has been developed by ASCIA to assist members in advising general practitioners and patients about the current temporary allergen immunotherapy supply issue.

 docASCIA template letter updated 10 Feb 2014101.5 KB  

ASCIA Sub-Cutaneous Immunotherapy (SCIT) Treatment Plan

Sub-Cutaneous Immunotherapy (SCIT) Treatment PlanTo access the PDF go to ASCIA Sub-Cutaneous Immunotherapy (SCIT) Treatment Plan 





ASCIA membership information and application forms are available on the ASCIA website:



Content updated November 2013

Disclaimer and Privacy

The ASCIA website is intended for use by ASCIA members, other health professionals, the general public and media. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...


Sponsors and Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites.

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.


This website is certified by Health On the Net Foundation. Click to verify.This site complies with the HONcode standard for trustworthy health information: verify here.

World Allergy Organization (WAO)

ASCIA is a WAO member society